122 related articles for article (PubMed ID: 10657995)
1. Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells.
Fabbrini MS; Carpani D; Soria MR; Ceriotti A
FASEB J; 2000 Feb; 14(2):391-8. PubMed ID: 10657995
[TBL] [Abstract][Full Text] [Related]
2. Pichia pastoris as a host for secretion of toxic saporin chimeras.
Lombardi A; Bursomanno S; Lopardo T; Traini R; Colombatti M; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
FASEB J; 2010 Jan; 24(1):253-65. PubMed ID: 19786581
[TBL] [Abstract][Full Text] [Related]
3. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.
Fabbrini MS; Carpani D; Bello-Rivero I; Soria MR
FASEB J; 1997 Nov; 11(13):1169-76. PubMed ID: 9367352
[TBL] [Abstract][Full Text] [Related]
4. Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.
Errico Provenzano A; Posteri R; Giansanti F; Angelucci F; Flavell SU; Flavell DJ; Fabbrini MS; Porro D; Ippoliti R; Ceriotti A; Branduardi P; Vago R
Microb Cell Fact; 2016 Nov; 15(1):194. PubMed ID: 27842546
[TBL] [Abstract][Full Text] [Related]
5. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism.
Ippoliti R; Lendaro E; Benedetti PA; Torrisi MR; Belleudi F; Carpani D; Soria MR; Fabbrini MS
FASEB J; 2000 Jul; 14(10):1335-44. PubMed ID: 10877826
[TBL] [Abstract][Full Text] [Related]
6. A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells.
Cavallaro U; del Vecchio A; Lappi DA; Soria MR
J Biol Chem; 1993 Nov; 268(31):23186-90. PubMed ID: 8226837
[TBL] [Abstract][Full Text] [Related]
7. The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
Zuppone S; Assalini C; Minici C; Bertagnoli S; Branduardi P; Degano M; Fabbrini MS; Montorsi F; Salonia A; Vago R
Sci Rep; 2020 Feb; 10(1):2521. PubMed ID: 32054892
[TBL] [Abstract][Full Text] [Related]
8. Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie MJ; Merlini G; Cazzola M
Br J Haematol; 1996 Jun; 93(4):789-94. PubMed ID: 8703804
[TBL] [Abstract][Full Text] [Related]
9. The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities.
Bagga S; Seth D; Batra JK
J Biol Chem; 2003 Feb; 278(7):4813-20. PubMed ID: 12466280
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of ribosome-inactivating protein saporin is not mediated through alpha2-macroglobulin receptor.
Bagga S; Hosur MV; Batra JK
FEBS Lett; 2003 Apr; 541(1-3):16-20. PubMed ID: 12706812
[TBL] [Abstract][Full Text] [Related]
11. Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers.
Flavell DJ; Boehm DA; Okayama K; Kohler JA; Flavell SU
Int J Cancer; 1994 Aug; 58(3):407-14. PubMed ID: 7519586
[TBL] [Abstract][Full Text] [Related]
12. The unusual stability of saporin, a candidate for the synthesis of immunotoxins.
Santanché S; Bellelli A; Brunori M
Biochem Biophys Res Commun; 1997 May; 234(1):129-32. PubMed ID: 9168975
[TBL] [Abstract][Full Text] [Related]
13. Targeting plant toxins to the urokinase and alpha 2-macroglobulin receptors.
Cavallaro U; Soria MR
Semin Cancer Biol; 1995 Oct; 6(5):269-78. PubMed ID: 8562904
[TBL] [Abstract][Full Text] [Related]
14. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
15. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo.
French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ
Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599
[TBL] [Abstract][Full Text] [Related]
16. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
17. Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells.
Vago R; Marsden CJ; Lord JM; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
FEBS J; 2005 Oct; 272(19):4983-95. PubMed ID: 16176271
[TBL] [Abstract][Full Text] [Related]
18. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein.
Chandler LA; Sosnowski BA; McDonald JR; Price JE; Aukerman SL; Baird A; Pierce GF; Houston LL
Int J Cancer; 1998 Sep; 78(1):106-11. PubMed ID: 9724101
[TBL] [Abstract][Full Text] [Related]
19. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a saporin isoform with lower ribosome-inhibiting activity.
Fabbrini MS; Rappocciolo E; Carpani D; Solinas M; Valsasina B; Breme U; Cavallaro U; Nykjaer A; Rovida E; Legname G; Soria MR
Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):719-27. PubMed ID: 9148741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
